Press Releases

03/27/2019

IQN Path Selects SeraCare Life Sciences for First-Ever Tumor Mutational Burden External Quality Assessment Program

SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, announced today their successful selection as a technology partner in support of the first ever tumor mutational burden (TMB) external quality assessment (EQA) program being developed by the International Quality Network for Pathology (IQN Path).

11/26/2018

LGC Acquires Seracare Life Sciences Strengthening Its Position in Clinical Quality Control Tools

Today, LGC announced the acquisition of SeraCare Life Sciences, Inc., a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories.

10/29/2018

SeraCare Announces Exclusive Partnership with AccuRef Diagnostics

SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, announced today an exclusive partnership with AccuRef Diagnostics, a Division of Applied StemCell, Inc., to market and sell their broad portfolio of CRISPR-engineered cell line reference materials.

10/22/2018

SeraCare Announces Launch of Expanded NTRK Reference Material Panel

SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, announced today the commercial launch of an expanded neurotrophic tropomyosin receptor kinase (NTRK) RNA fusion reference material panel developed in a partnership with Bayer.

09/12/2018

Pioneering Survey of Clinical NGS QC Practices Proves Need for Purpose-Built QC Solutions to Standardize Industry

SeraCare Life Sciences has partnered with GenomeWeb to conduct a first-of-its-kind survey for clinical NGS labs with over 150 respondents providing comprehensive data detailing their QC management programs.

07/25/2018

SeraCare Announces the Expansion of Their Proprietary AccuPlex™ Technology Product Portfolio with the Launch of the AccuSpan™ HCV RNA Linearity Panel

Announcing the launch of their all-new AccuSpan™ HCV RNA Linearity Panel – the latest product built with their proprietary AccuPlex™ recombinant technology

04/17/2018

SeraCare Partners with NAVICAN on Implementation of Best-In-Class QC Workflow for TheraMap Precision Cancer Care™ Services

Leading NGS QC Software is integrated into their Philips IntelliSpace Genomics Platform

04/16/2018

SeraCare Announces Expansion of Industry’s Most Complete and Patient-Like ctDNA Reference Materials

Comprehensive circulating tumor DNA reference materials for NGS assay development, validation, and daily run controls

02/13/2018

SeraCare Announces Industry’s First CNV-Specific Reference Material for Gene Amplifications in Breast, Lung, and Brain Cancer

Truth-set NGS reference materials that broaden capabilities for tumor profiling assay validation and QC

01/08/2018

SeraCare Life Sciences Announces Joe Bernardo as New Company Chairman

SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, today announced that Joe Bernardo has joined SeraCare’s board of directors in the role of Chairman

11/08/2017

SeraCare Announces Industry's First Comprehensive NGS Reference Material for Hematologic Malignancies

Truth-set NGS reference materials to significantly advance validation and QC of myeloid assays

08/01/2017

SeraCare Announces the Launch of a Suite of Zika Virus Reference Materials for Improved Diagnostic Testing

Comprehensive suite of Zika IgM and recombinant Zika virus reference materials for method validation and evaluation of serological and molecular infectious disease assays.

07/18/2017

SeraCare Life Sciences Announces the Most Patient-Like cfDNA QC Technology

Truth set ctDNA materials to significantly advance the development and validation of liquid biopsy assays

06/27/2017

SeraCare announces QC software enhancements for higher confidence in NGS assay performance

iQ NGS QC Management software provides clinical NGS labs the tools and analytics necessary to easily assess, maintain, and demonstrate assay performance

03/23/2017

SeraCare Life Sciences announces launch of industry’s first multiplexed Inherited Cancer reference material

Expert-designed material for simplified validation of NGS-based panels

02/21/2017

SeraCare Life Sciences Announces New Highly Multiplexed Fusion RNA Assay Reference Standards

With Purified and FFPE formats, these standards are compatible with leading NGS-based Fusion RNA panels

02/14/2017

SeraCare Announces ‘Catalyzing Implementation of NGS-Based Tests’: A Four-Part Webinar Series

In partnership with GenomeWeb, these live presentations bring together clinical genomics industry key opinion leaders to discuss practical examples and best practices

02/08/2017

SeraCare Life Sciences Announces Presentation on Enabling Clinical Genomics with Highly Multiplexed Reference Materials

In partnership with Xtalks, this live webinar highlights a clinical laboratory case study

11/11/2016

SeraCare Launches Two New Seraseq™ Reference Materials for Clinical Oncology Assays

7-plex FFPE KRAS and updated RUO-GMP version of 40-plex Tumor Mutation DNA Mix now available

11/10/2016

SeraCare Life Sciences to Support Non-Invasive Prenatal Testing (NIPT) Proficiency Program in Collaboration with UK NEQAS

Seraseq™ Aneuploidy Reference Materials to be used in one of the first widespread NIPT external quality assessment (EQA) programs